1-7 of 7
Hao Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P241: A highly potent HPK1 inhibitor augments immune cell activation and anti-tumor immunity in a syngeneic tumor mouse model

Hao Liu, Lei Wu, Song Feng, Wei Huang, Huijuan Li, Jing Lin, Yangyang Liu, Liufeng Mei, Baoqi Ren, Julie Xie, Lili Yao, Wenge Zhong
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P241.
DOI: https://doi.org/10.1158/1535-7163.TARG-21-P241
Published: 01 December 2021
View article
Journal Articles

Abstract PR01: A phase I study targeting the APE1/Ref-1 DNA repair-redox signaling protein with the APX3330 inhibitor

Mark R. Kelley, Safi Shahda, Nehal J. Lakhani, Bert O'Neil, Lincy Chu, Amanda K. Anderson, Jun Wan, Amber L. Mosley, Hao Liu, Richard A. Messmann
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): PR01.
DOI: https://doi.org/10.1158/1535-7163.TARG-19-PR01
Published: 01 December 2019
View article
Journal Articles

Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells

Bryan Wei Chen, Wei Chen, Hui Liang, Hao Liu, Chao Liang, Xiao Zhi, Li-qiang Hu, Xia-Zhen Yu, Tao Wei, Tao Ma, Fei Xue, Lei Zheng, Bin Zhao, Xin-Hua Feng, Xue-li Bai, Ting-bo Liang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (8): 1805–1815.
DOI: https://doi.org/10.1158/1535-7163.MCT-15-0029
Published: 05 August 2015
View article
PDF
Includes: Supplementary data
Journal Articles

Deubiquitinase Inhibition of 19S Regulatory Particles by 4-Arylidene Curcumin Analog AC17 Causes NF-κB Inhibition and p53 Reactivation in Human Lung Cancer Cells

Binhua Zhou, Yinglin Zuo, Baojian Li, Hao Wang, Hao Liu, Xianfeng Wang, Xu Qiu, Yun Hu, Shijun Wen, Jun Du, Xianzhang Bu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (8): 1381–1392.
DOI: https://doi.org/10.1158/1535-7163.MCT-12-1057
Published: 08 August 2013
View article
PDF
Journal Articles

B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation

Hao Liu, Christina Tekle, Yih-Wen Chen, Alexandr Kristian, Yuhua Zhao, Ming Zhou, Zixing Liu, Yan Ding, Bin Wang, Gunhild Mari Mælandsmo, Jahn Marthin Nesland, Oystein Fodstad, Ming Tan
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (6): 960–971.
DOI: https://doi.org/10.1158/1535-7163.MCT-11-0072
Published: 08 June 2011
View article
PDF
Includes: Supplementary data
Journal Articles

Contrasting Effects of Nutlin-3 on TRAIL- and Docetaxel-Induced Apoptosis Due to Upregulation of TRAIL-R2 and Mcl-1 in Human Melanoma Cells

Hsin-Yi Tseng, Chen Chen Jiang, Amanda Croft, Kwang Hong Tay, Rick Francis Thorne, Fan Yang, Hao Liu, Peter Hersey, Xu Dong Zhang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (12): 3363–3374.
DOI: https://doi.org/10.1158/1535-7163.MCT-10-0646
Published: 14 December 2010
View article
PDF
Journal Articles

MAC-321, a novel taxane with greater efficacy than paclitaxel and docetaxel in vitro and in vivo

Deepak Sampath, Carolyn M. Discafani, Frank Loganzo, Carl Beyer, Hao Liu, Xingzhi Tan, Sylvia Musto, Tami Annable, Patricia Gallagher, Carol Rios, Lee M. Greenberger
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2003) 2 (9): 873–884.
Published: 10 October 2003
View article
PDF